Showing results (341-350 of 354) with videos related to

Sort By:
Pageof 36
Plos Pathogens|June 27, 2014
Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liverJuandy Jo, Anthony T Tan, James E Ussher, et al.
European Journal of Immunology|January 3, 2013
Conditional ligands for Asian HLA variants facilitate the definition of CD8+ T-cell responses in acute and chronic viral diseasesCynthia X L Chang, Anthony T Tan, Ming Yan Or, et al.
Plos One|July 23, 2014
A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearanceThomas H King, Charles B Kemmler, Zhimin Guo, et al.
The Journal of Infectious Diseases|July 21, 2021
The Inflammatory Cytokine Profile Associated With Liver Damage Is Broader and Stronger in Patients With Chronic Hepatitis B Compared to Patients With Acute Hepatitis BAlexandra Johnson Valiente, Kin Seng Liem, Kathleen B Schwarz, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 16, 2025
Peginterferon λ for the treatment of patients admitted to hospital with COVID-19: a phase 2, placebo-controlled randomized trialChristopher Kandel, Mia J Biondi, Mark Gillrie, et al.
The Lancet. Gastroenterology & Hepatology|April 15, 2019
A global scientific strategy to cure hepatitis BPeter A Revill, Francis V Chisari, Joan M Block, et al.
Biorxiv : the Preprint Server for Biology|March 26, 2024
B Cells Promote T Cell Immunosenescence and Mammalian Aging ParametersSaad Khan, Mainak Chakraborty, Fei Wu, et al.
Science Immunology|June 2, 2017
Type I Interferon Responses Drive Intrahepatic T cells to Promote Metabolic SyndromeMagar Ghazarian, Xavier S Revelo, Mark K Nøhr, et al.
Nature Reviews. Gastroenterology & Hepatology|October 13, 2025
Towards a reference cell atlas of liver diversity over the human lifespanSarah A Taylor, Gary D Bader, Sonya MacParland, et al.
The Lancet. Respiratory Medicine|February 8, 2021
Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trialJordan J Feld, Christopher Kandel, Mia J Biondi, et al.
Pageof 36